9BX Stock Overview
Develops and commercializes mobile electronic breathalyzers for the consumers markets, businesses, and health care providers.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Deversify Health AB (publ) Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | SEK 0.0006 |
52 Week High | SEK 0.015 |
52 Week Low | SEK 0.0002 |
Beta | 0 |
11 Month Change | -40.00% |
3 Month Change | -89.66% |
1 Year Change | -95.52% |
33 Year Change | -99.91% |
5 Year Change | n/a |
Change since IPO | -99.86% |
Recent News & Updates
Recent updates
Shareholder Returns
9BX | DE Software | DE Market | |
---|---|---|---|
7D | 0% | 0.3% | -1.0% |
1Y | -95.5% | 66.9% | 16.1% |
Return vs Industry: 9BX underperformed the German Software industry which returned 71.5% over the past year.
Return vs Market: 9BX underperformed the German Market which returned 18.1% over the past year.
Price Volatility
9BX volatility | |
---|---|
9BX Average Weekly Movement | 134.6% |
Software Industry Average Movement | 5.0% |
Market Average Movement | 5.0% |
10% most volatile stocks in DE Market | 10.9% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 9BX's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 9BX's weekly volatility has increased from 80% to 135% over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | n/a | Lotta Thornqvist | deversify.com |
Deversify Health AB (publ) develops and commercializes mobile electronic breathalyzers for the consumers markets, businesses, and health care providers. The company offers Acetrack, a ketone breathalyzer to determine whether a person is found to be in ketosis or not; and Elitista, a health education platform that provides customers with knowledge and tools to learn about their own metabolic health. The company is headquartered in Uppsala, Sweden.
Deversify Health AB (publ) Fundamentals Summary
9BX fundamental statistics | |
---|---|
Market cap | €23.95k |
Earnings (TTM) | €0 |
Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs 9BX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
9BX income statement (TTM) | |
---|---|
Revenue | €0 |
Cost of Revenue | €0 |
Gross Profit | €0 |
Other Expenses | €0 |
Earnings | €0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did 9BX perform over the long term?
See historical performance and comparison